RV1729 matching placebo single dose

DRUG2 trials

Sponsors

Respivert Ltd

Conditions

AsthmaHealthy Volunteers

Phase 1

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729

CompletedNCT01813084

Respivert LtdAsthma, Healthy Volunteers

Start: 2013-05-31End: 2014-04-30Updated: 2014-04-24

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 for up to 28 Days

CompletedNCT02140320

Respivert LtdAsthma, Healthy Volunteers

Start: 2014-07-31End: 2015-03-31Updated: 2015-04-14